Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  ResMed, Inc.    RMD

RESMED, INC.

(RMD)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 01/26 11:44:46 am
221.03 USD   -0.29%
01/24RESMED : Ord Minnett rates RMD as Lighten
AQ
01/19INSIDER TRENDS : 90-Days of Insider Buying at ResMed Interrupted with Share Disposition
MT
01/13RESMED : 39th Annual J.P. Morgan Healthcare Conference
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • The company is in a robust financial situation considering its net cash and margin position.
  • For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock
  • The stock is in a well-established, long-term rising trend above the technical support level at 160.69 USD
Weaknesses
  • Based on current prices, the company has particularly high valuation levels.
  • The firm trades with high earnings multiples: 45.96 times its 2021 earnings per share.
  • The company is not the most generous with respect to shareholders' compensation.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
Ratings chart
Sector Advanced Medical Equipment & Technology - Other
1st jan.Capitalisation (M$)Investor Rating
RESMED, INC.1.39%32 125
THERMO FISHER SCIENTIFIC10.48%205 631
DANAHER CORPORATION7.21%169 176
SHENZHEN MINDRAY BIO-MEDICA..14.55%91 552
INTUITIVE SURGICAL, INC.-8.08%88 403
ILLUMINA, INC.13.78%61 466
SIEMENS HEALTHINEERS AG4.34%56 867
EDWARDS LIFESCIENCES CORPOR..-5.85%53 531
BOSTON SCIENTIFIC CORPORATI..2.31%52 666
KONINKLIJKE PHILIPS N.V.6.65%51 496
AGILENT TECHNOLOGIES, INC.5.90%38 503
OLYMPUS CORPORATION-8.86%25 477
CERNER CORPORATION2.57%24 680
HOLOGIC, INC.4.82%19 670
WATERS CORPORATION10.59%16 961
PERKINELMER, INC.5.26%16 914
More Results
Financials (USD)
Sales 2021 3 144 M - -
Net income 2021 692 M - -
Net Debt 2021 252 M - -
P/E ratio 2021 46,0x
Yield 2021 0,72%
Capitalization 32 125 M 32 125 M -
EV / Sales 2021 10,3x
EV / Sales 2022 9,41x
Nbr of Employees 7 770
Free-Float 77,0%
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes